ReviewInterventional cardiology (London, England)2022
A Review of the Impella Devices.
Review in Interventional cardiology (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
62 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Concurrent Use of Kidney Replacement Therapy and Temporary Left Ventricular Assist Device in Cardiogenic Shock: A Systematic Review and Meta-Analysis.Blood purification · 2025Pooled it
- Axial Flow Percutaneous Ventricular Assist Devices: Physiology, Procedural Considerations, and Clinical Applications-A State-of-the-Art Review.Structural heart : the journal of the Heart Team · 2026Review
- Article
- Evaluation of Bleeding Rates With Sodium Bicarbonate Versus Heparin-Based Purge Solutions for Impella CP and 5.5 Ventricular Assist Devices.Artificial organs · 2026Article
- Cardiorenal Hemodynamic Coupling: Mechanical Circulatory Support Augments Renal Blood Flow via Renal Vasodilation.JACC. Basic to translational science · 2026Article
- Microaxial Left Ventricular Assist Device as Bridge to Transplantation in Postinfarction Left Ventricular Pseudoaneurysm.JACC. Case reports · 2026Article
- Comparative Outcomes of Transferred vs Nontransferred Cardiogenic Shock Patients Receiving Impella Support.JACC. Advances · 2026Article
- Anesthetic Management in Patients with Impella Devices: A Retrospective Review and Clinical Guide.Annals of cardiac anaesthesia · 2026Article
- Impact of prolonged microaxial flow pump support on outcomes in heart transplantation: A single-center experience.JTCVS open · 2026Article
- Mechanical circulatory support in cardiogenic shock: a contemporary head-to-head comparison.Heart failure reviews · 2026Review
- Echocardiographic Assessment Before, During, and After Impella Positioning: State of the Art.Journal of clinical medicine · 2026Review
- Article
- Left ventricular perforation following impella® CP placement in a resuscitated STEMI patient with cardiogenic shock: a rare complication and case report.European heart journal. Case reports · 2026Article
- Axillary Artery Thrombosis After LVAD Explantation Managed With Thrombectomy and Stenting.JACC. Case reports · 2026Article
- Management of femoral large-bore access and closure during microaxial flow pump-supported interventions.Frontiers in cardiovascular medicine · 2026Review
- Cardiogenic Shock Management in the Modern Era: A Narrative Review of Percutaneous Mechanical Circulatory Support Devices.Journal of cardiovascular development and disease · 2025Review
- Impact of the United Network for Organ Sharing allocation criteria changes on temporary mechanical circulatory support use as a bridge to transplant.World journal of transplantation · 2025Review
- A case of fatal acute saddle embolism of the terminal aorta after long-term support using Impella CP.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2025Article
- Special topics: heart failure-related cardiogenic shock, valvular heart disease and end-stage renal disease. Part 4 of the International Expert Opinion Series on Acute Heart Failure Management.Heart failure reviews · 2025Review
- Circulatory Support for High-Risk Coronary Artery Bypass Grafting and Coronary Interventions: Where is the Evidence?The International journal of angiology : official publication of the International College of Angiology, Inc · 2025Review
2 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The use of mechanical circulatory support (MCS) to provide acute haemodynamic support for cardiogenic shock or to support high-risk percutaneous coronary intervention (HRPCI) has grown over the past decade. There is currently no consensus on best practice regarding its use in these two distinct indications. Impella heart pumps (Abiomed) are intravascular microaxial blood pumps that provide temporary MCS during HRPCI or in the treatment of cardiogenic shock. The authors outline technical specifications of the individual Impella heart pumps and their accompanying technology, the Automated Impella Controller and SmartAssist, their indications for use and patient selection, implantation techniques, device weaning and escalation, closure strategies, anticoagulation regimens, complications, future directions and upcoming trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.